SCHEMBL583663

SCHEMBL583663

COCCOC(C(=O)O)C1CC(C)CCC1C(C)C

nearest known ligand 0.41

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 3/20 0.41
TRPM8 Q7Z2W7 5/20 0.39
TRPA1 O75762 2/20 0.39
ALDH1A1 P00352 2/20 0.37
TRPV1 Q8NER1 3/20 0.36
KCNA5 P22460 1/20 0.35
LMNA P02545 1/20 0.35
CYP19A1 P11511 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30772345 0.88 EPHX1 (0.38) EPHX1TRPM8TRPA1ALDH1A1TRPV1
SCHEMBL29561496 0.87 EPHX1 (0.42) EPHX1TRPM8TRPA1ALDH1A1TRPV1
SCHEMBL80852 0.87 EPHX1 (0.42) EPHX1TRPM8TRPA1ALDH1A1TRPV1
SCHEMBL16041029 0.85 EPHX1 (0.38) EPHX1TRPM8TRPA1ALDH1A1TRPV1
SCHEMBL8375721 0.84 TRPM8 (0.47) EPHX1TRPM8TRPA1ALDH1A1TRPV1
SCHEMBL583712 0.82 EPHX1 (0.47) EPHX1TRPM8TRPA1ALDH1A1TRPV1
SCHEMBL5690453 0.82 EPHX1 (0.47) EPHX1TRPM8TRPA1ALDH1A1TRPV1
SCHEMBL9951715 0.72 EPHX1 (0.53) EPHX1TRPM8TRPA1TRPV1KCNA5
SCHEMBL1030886 0.72 EPHX1 (0.53) EPHX1TRPM8TRPA1ALDH1A1TRPV1
SCHEMBL3274993 0.72 EPHX1 (0.53) EPHX1TRPM8TRPA1TRPV1KCNA5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 603 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240058243-A1 A METHOD FOR FIGHTING MICROORGANISMS USING MENTHOL DERIVATIVES SYMRISE AG (DE) 2024-02-22 US claimed
EP-4259287-A1 A METHOD FOR FIGHTING MICROORGANISMS USING MENTHOL DERIVATIVES Symrise AG (DE) 2023-10-18 EP claimed
EP-3081207-B1 USE OF A LIPOSOME COMPOSITION SYMRISE AG (DE) 2022-09-21 EP claimed
WO-2022122144-A1 A METHOD FOR FIGHTING MICROORGANISMS USING MENTHOL DERIVATIVES SYMRISE AG (DE) 2022-06-16 WO claimed
EP-3687311-A1 AMIDES FOR GENERATING A TRIGEMINAL EFFECT Symrise AG (DE) 2020-08-05 EP claimed
EP-3142499-B1 HOMOVANILLIC ACID ESTERS, IN PARTICULAR FOR ACHIEVING AN IMPRESSION OF HEAT AND/OR SPICINESS SYMRISE AG (DE) 2019-10-30 EP claimed
US-10392371-B2 Compounds useful as modulators of TRPM8 SENOMYX, INC. (US) 2019-08-27 US claimed
US-20190099342-A1 COOLING PRODUCT SYMRISE AG (DE) 2019-04-04 US claimed
WO-2019063069-A1 AMIDES FOR GENERATING A TRIGEMINAL EFFECT SYMRISE AG (DE) 2019-04-04 WO claimed
EP-3142499-A1 HOMOVANILLIC ESTER, MORE PARTICULARLY FOR ACHIEVING AN IMPRESSION OF HEAT AND/OR SPICINESS Symrise AG (DE) 2017-03-22 EP claimed
WO-2016166038-A1 WHITENING COMPOSITIONS SYMRISE AG (DE) 2016-10-20 WO claimed
EP-3081207-A1 WHITENING COMPOSITIONS Symrise AG (DE) 2016-10-19 EP claimed
WO-2015158677-A1 HOMOVANILLIC ESTER, MORE PARTICULARLY FOR ACHIEVING AN IMPRESSION OF HEAT AND/OR SPICINESS SYMRISE AG (DE) 2015-10-22 WO claimed
EP-2932858-A1 Homovanillic acid esters, in particular for achieving an impression of heat and/or spiciness Symrise AG (DE) 2015-10-21 EP claimed
EP-2008530-B1 Aroma composition for reducing or suppressing unwanted bitter and astringent impressions SYMRISE AG (DE) 2011-01-19 EP claimed
EP-2008530-A1 Aroma composition for reducing or suppressing unwanted bitter and astringent impressions Symrise GmbH & Co. KG (DE) 2008-12-31 EP claimed
EP-1541039-B1 Flavour composition comprising cubebol and a further refreshing agent FIRMENICH & CIE (CH) 2008-01-02 EP claimed
EP-4103144-B1 COMPOSITIONS COMPRISING UV-FILTERS AND ONE OR MORE (BIO)-ALKANEDIOLS SYMRISE AG (DE) 2026-05-27 EP disclosed
EP-1529095-A1 CARVONE ACETALS USED AS FLAVOURINGS Symrise GmbH & Co. KG (DE) 2005-05-11 EP disclosed
WO-2004015044-A1 CARVONE ACETALS USED AS FLAVOURINGS SYMRISE GMBH & CO. KG (DE) 2004-02-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190099342-A1 COOLING PRODUCT TRPA1, TRPV2, NISCH EPHX1 1636/4885TRPM8 44/4885TRPA1 1/4885
US-20240058243-A1 A METHOD FOR FIGHTING MICROORGANISMS USING MENTHOL DERIVATIVES MGLL, GCDH, GK EPHX1 1246/4885TRPM8 84/4885TRPA1 187/4885
US-10392371-B2 Compounds useful as modulators of TRPM8 TRPM8, TRPM4, TRPM6 EPHX1 4010/4885TRPM8 1/4885TRPA1 8/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.